| Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein J Laurson, S Khan, R Chung, K Cross, K Raj Carcinogenesis 31 (5), 918-926, 2010 | 186 | 2010 |
| Hepatocyte progenitors in man and in rodents–multiple pathways, multiple candidates J Laurson, C Selden, HJF Hodgson International journal of experimental pathology 86 (1), 1-18, 2005 | 63 | 2005 |
| Growth factors improve gene expression after lentiviral transduction in human adult and fetal hepatocytes C Selden, N Mellor, M Rees, J Laurson, M Kirwan, D Escors, M Collins, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2007 | 35 | 2007 |
| Putative human liver progenitor cells in explanted liver J Laurson, C Selden, M Clements, D Mavri-Damelin, S Coward, ... Cells Tissues Organs 186 (3), 180-191, 2007 | 22 | 2007 |
| Localisation of human papillomavirus 16 E7 oncoprotein changes with cell confluence J Laurson, K Raj PLoS One 6 (6), e21501, 2011 | 19 | 2011 |
| Ethical use of off-label disease-modifying therapies for multiple sclerosis J Laurson-Doube, N Rijke, A Helme, P Baneke, B Banwell, ... Multiple Sclerosis Journal 27 (9), 1403-1410, 2021 | 8 | 2021 |
| World Health Organization essential medicines list: Multiple sclerosis disease-modifying therapies application J McDonell, K Costello, J Laurson-Doube, N Rijke, G Giovannoni, ... Multiple Sclerosis Journal 26 (2), 153-158, 2020 | 8 | 2020 |
| Health-care disparities for people with multiple sclerosis J Laurson-Doube, N Rijke, K Costello, J McDonell, G Giovannoni, ... The Lancet Neurology 19 (3), 207-208, 2020 | 5 | 2020 |
| Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting project MG Celani, F Nonino, K Mahan, M Orso, B Ridley, E Baldin, AA Bignamini, ... Multiple Sclerosis and Related Disorders 60, 103688, 2022 | 2 | 2022 |
| Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosis T Piggott, F Nonino, E Baldin, G Filippini, N Rijke, H Schünemann, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 7 (4 …, 2021 | 2 | 2021 |
| Global synergistic actions to improve brain health for human development MO Owolabi, M Leonardi, C Bassetti, J Jaarsma, T Hawrot, AI Makanjuola, ... Nature Reviews Neurology, 1-13, 2023 | 1 | 2023 |
| The isolation, characterisation and culture of putative human liver progenitor cells J Laurson PQDT-Global, 2006 | | 2006 |
| Cell colonies expressing both hepatocytes and biliary epithelial cell markers can be isolated from non-parenchymal cells of alcohol cirrhotic liver explants J Laurson, MO Clements, D Mavri, C Selden, HJF Hodgson | | 2004 |
| A proliferating population of human cells expressing hepatocyte and biliary epithelial cell markers cultured long term in non-differentiating conditions J Laurson, D Mavri, C Selden, P Oakley, H Hodgson | | 2003 |
| The effect of epidermal growth factor (EGF) and hepatocyte growth factor (HGF) on FAS-ligand binding-induced apoptosis in primary human hepatocytes RC Saich, C Selden, P Oakley, J Laurson, H Hodgson | | 2003 |
| Epidermal growth factor protects primary human hepatocytes against fas-ligand binding induced apoptosis in-vitro RC Saich, C Selden, P Oakley, J Laurson, H Hodgson | | 2003 |
Gavin GiovannoniBarts and The London School of Medicine and DentistryBestätigte E-Mail-Adresse bei giovannoni.net
